In a major development for diabetes care in India, Dr. Reddy's Labs has got the go-ahead from the Subject Expert Committee ...

Orforglipron, a novel oral GLP-1, was superior to dapagliflozin for reducing HbA1c in adults with type 2 diabetes ...

The first-of-its-kind drug doesn’t just regrow hair—it could cure premature graying, too. An old wives’ tale claims male ...

High School Musical alum Ashley Tisdale detailed her decision not to use Ozempic to assist with weight loss after giving ...

Adocia and Tonghua Dongbao have announced positive topline results from a phase 3 clinical trial of BioChaperone Lispro ...

California will start selling low-cost insulin on Jan. 1, nearly three years after Gov. Gavin Newsom announced a plan to make ...

The Subject Expert Committee (SEC), functional under the Central Drugs Standard Control Organisation (CDSCO), has asked ...

High School Musical' alum Ashley Tisdale said she doesn't judge people who take Ozempic, but it's not the right choice for ...

The age of the GLP-1 drug has reached yet another milestone, with the US Food and Drug Administration green-lighting Novo Nordisk's once-daily oral semaglutide pill to treat people at high risk of ...

We came across a bullish thesis on Eli Lilly and Company on Kontra Investments’s Substack by Kontra. In this article, we will ...

After beating Novo Nordisk’s semaglutide last month, Lilly’s much anticipated oral candidate orforglipron has taken down ...

Gov. Gavin Newsom said Thursday that California will begin selling affordable insulin under its own label on Jan. 1, nearly ...